Cancer Research
Double H10/Ki-67 immunostaining is useful to study breast cancer growth fraction
Published in Health and Medicine Week, December 26th, 2005
According to a study from Bulgaria, "Histone H10 is a linker histone subvariant present in tissues of low proliferation rate. It is supposed to participate in the expression and maintenance of the terminal differentiation phenotype."
N.N. Kostova and colleagues at the Institute of Molecular Biology in Sofia wrote, "We proposed to study histone H10 distribution in human breast carcinoma and its relationship with the processes of proliferation and differentiation. Most of the cells in carcinomas of moderate and high...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Cardiology
Cardiopulmonary medicine began in 1940s with right-heart catheterization - Complementary & Alternative Medicine
Study cites use of glucosamine, chondroitin combination as being effective for joint health - Fitness & Wellness
Personal fulfillment may motivate adolescents to be physically active - Infectious Diseases
Medical soldiers protect world borders from infectious diseases - Medical Devices
Pricing simplified for Invisalign products - Accreditation
Cirrus Health announces Linden Crest Surgery Center passes AAAHC inspection - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
